• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Genesys Capital

edit

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.

Milestones

edit

• 
  Genesys Capital invested in Tioga Pharmaceuticals. (4/12/12)
  Posted 4/12/12 at 6:06pm via tiogapharma.com
• 
  Genesys Capital invested in Functional Neuromodulation. (10/17/11)
  Posted 10/18/11 at 10:05pm via biospace.com
• 
  Genesys Capital invested in Naurex. (5/11/11)
  Posted 5/11/11 at 7:32pm via fiercebiotech.com
• 
  Genesys Capital invested in StemPath. (2/24/06)
  Posted 4/30/10 at 11:05pm via thefreelibrary.com
• 
  Genesys Capital invested in Millenium Biologix. (8/18/06)
  Posted 4/30/10 at 4:15am
• 
  Genesys Capital invested in Tioga Pharmaceuticals. (2/17/10)
  Posted 2/19/10 at 5:02am via tiogapharma.com
• 
  Genesys Capital invested in Allostera Pharma. (7/27/09)
  Posted 7/27/09 at 4:22pm via onbiovc.com

Investments

Videos

Sources

1. Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome (tiogapharma.com) [edit]
2. Functional Neuromodulation Inc. Closes $10.4 Million Financing (biospace.com) [edit]
3. Naurex raises $18M for Ph2 depression program (fiercebiotech.com) [edit]
4. Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome (tiogapharma.com) [edit]
5. Allostera Pharma, Inc.: Series C $15.4M (onbiovc.com) [edit]
6. Cap Funding Report [edit]
7. StemPath Inc. Announces $1 Million Private Financing. (thefreelibrary.com) [edit]